ACETO Board of Directors Declares Quarterly Cash Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Aceto Corp (ACET) Tops Q3 EPS by 4c
September 4, 2014 5:01 PM EDTAceto Corp (NASDAQ: ACET) reported Q3 EPS of $0.21, $0.04 better than the analyst estimate of $0.17. Revenue for the quarter came in at $139.6 million versus the consensus estimate of $134.23 million.
"ACETO made significant progress during fiscal 2014 toward our long-term strategy of becoming a more human health-oriented company. An expanded and enhanced management team at our generic drug division, Rising Pharmaceuticals, the acquisition of the generic pharmaceutical company, PACK Pharmaceuticals, including its robust product pipeline, new finished dose product launches and a near doubling of research and development spend versus fiscal 2013 all contributed to this progress.... More
ACETO Corp. (ACET) Declares $0.06 Quarterly Dividend; 1.4% Yield
September 4, 2014 12:19 PM EDT(Updated - September 4, 2014 3:09 PM EDT)
ACETO Corp. (NASDAQ: ACET) declared a quarterly dividend of $0.06 per share, or $0.24 annualized.
The dividend will be payable on September 26, 2014, to stockholders of record on September 15, 2014, with an ex-dividend date of September 11, 2014.
The annual... More
